PLK4 and skin basal cell carcinoma: Inhibition of PLK4 using CFI-400945 and centrinone and genetic manipulation has shown significant growth inhibitory effects in vitro in cSCC and BCC cells and reduced tumorigenesis in a mouse xenograft model.134